Services
Genomic Testing
Companion Diagnostic Test
Laboratory Developed Tests (LDT)
Solid Tumors
Hematologic Malignancies
Hereditary Cancers
Minimal Residual Disease
RUO Kit Solution
Research Services
Platforms
DNA Sequencing
RNA Sequencing
Other Services
Technology
Our Technology
Publications
Partnerships
About Us
What is Precision Oncology?
Our Company
Our Team
Certificates & Accreditation
News
Join Us
Contact Us
Ch|中文
Search
May 16, 2023
Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer
by Geneseeq
August 3, 2022
GENESEEQ AND COLLABORATORS SHARE NEW FINDINGS AT WORLD CONFERENCE ON LUNG CANCER 2022
by Geneseeq
July 5, 2022
Geneseeq and collaborators publish new findings from DECIPHER series, exploring single cfDNA feature-based machine learning model for lung cancer early detection
by Geneseeq
Privacy Preference Center
Privacy Preferences
